The quantitative range and reproducibility of current serological tests for severe acute
respiratory syndrome coronavirus-2 (SARS-CoV-2) are not optimized. Herein, we developed a …

Introduction Information on the effectiveness of personal protective equipment (PPE) for
preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among …

In early 2020, Japan repatriated 566 nationals from China. Universal laboratory testing and
14-day monitoring of returnees detected 12 cases of severe acute respiratory syndrome …

Objective To evaluate the efficacy and safety of direct hemoperfusion using a polymyxin B‐immobilized
polystyrene column (PMX‐DHP) in severe acute respiratory syndrome …

We read with great interest the article ‘Characteristics associated with hospitalisation for
COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology …

Abstract An expanded myeloid cell compartment is a hallmark of severe coronavirus disease
2019 (COVID-19). However, data regarding myeloid cell expansion have been collected in …

Interventions: Not applicable. Measurements and Main Results: This is single-center study,
national center hospital designated for infectious disease. Fifty-eight patients who tested …

Due to the significant spread of a new type of coronavirus (SARS-CoV-2) infection (COVID-19)
in China, the Chinese government blockaded several cities in Hubei Province. Japanese …

To the Editor, Coronavirus disease 2019 (COVID‐19) is ongoing and spreading worldwide
after cases of COVID‐19 were reported in Wuhan, China in December 2019. 1 Older age, …

The aim of this study was to describe the clinical and radiological findings of COVID-19
patients with “silent hypoxia,” who had no dyspnea on admission even though their oximetry …